Popular Weight Loss Drugs Like Wegovy May Also Target Arthritis Inflammation

Researchers have discovered that GLP-1 hormone, targeted by weight loss medications like Wegovy and Ozempic, is present in joint tissues of arthritis patients at surprisingly low levels. This finding suggests that high-dose GLP-1 medications could potentially reach inflamed joints directly and reduce inflammation independently of weight loss effects. The discovery may revolutionize arthritis treatment by opening entirely new therapeutic pathways. For arthritis patients, this research could mean access to repurposed medications with dual benefits or the development of new joint-specific treatments.